BMF and hepatocellular carcinoma: For instance, MiR-193a-5p has been reported to promote abnormal proliferation and limit apoptosis of HCC cells by targeting the downstream gene BMF, suggesting that miR-193a-5p/BMF axis could be potential therapeutic sites in HCC treatment (42).